N-Nitroso Osimertinib 3-Hydroxy Impurity
✓
데이터 정확도 100%
연중무휴 과학적 지원
⬡
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

N-Nitroso Osimertinib 3-Hydroxy Impurity

● Under Development

카탈로그 번호:VE0025909
CAS 번호:N/A
분자식:C28H34N8O4
분자량:546.62 g/mol

에 대한 추가 정보

모약물

Osimertinib

IUPAC명

N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)(nitroso)amino)phenyl)-3-hydroxypropanamide

Pharmacopeial Synonyms

N/A

동의어

N/A

SMILES

O=C(CCO)NC1=C(N(CCN(C)C)C)C=C(OC)C(N(N=O)C2=NC(C3=CN(C)C4=C3C=CC=C4)=CC=N2)=C1

InChI

InChI=1S/C28H34N8O4/c1-33(2)13-14-34(3)24-17-26(40-5)25(16-22(24)30-27(38)11-15-37)36(32-39)28-29-12-10-21(31-28)20-18-35(4)23-9-7-6-8-19(20)23/h6-10,12,16-18,37H,11,13-15H2,1-5H3,(H,30,38)

설명

N-Nitroso Osimertinib 3-Hydroxy Impurity is a nitrosamine-derived degradation product characterized by nitrosation of the Osimertinib scaffold with a 3-hydroxy substitution, posing analytical and control challenges in drug substance development. This polar impurity is typically monitored by LC-HRMS and LC-MS/MS for accurate mass and fragmentation patterns, with orthogonal confirmation by 1H and 13C NMR and HPLC-UV retention profiling. Formation pathways include nitrosation under acidic or oxidative conditions and hydroxylation during synthesis or storage. Effective control strategies include optimization of synthetic routes, elimination of nitrosating reagents, validated purification and desalting steps, and stability testing with established limits.

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url